Document Detail


Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis.
MedLine Citation:
PMID:  9829886     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Following renal artery angioplasty and stenting, a female hypertensive patient suffered left renal artery stent subacute thrombosis. A second successful angioplasty was performed using 5000 U heparin i.v. and 0.25-mg/kg bolus followed by a 12-hr 10-microg/min infusion of abciximab. Normal renal flow was re-established and remained normal at 1-year follow-up.
Authors:
D C Berkompas
Related Documents :
1476966 - Renovascular hypertension in a newborn: necessity of assessing blood pressure routinely.
446496 - Renal arterial thrombosis after the contralateral removal of a pelvic kidney.
11522876 - Helical ct angiography in evaluation of live kidney donors.
3051136 - Additional extrarenal abnormalities seen in tc-99m dtpa renal flow study.
12901816 - Unusual complication of ingestion of a foreign body.
8768776 - Congenitally absent pulmonary veins--diagnostic pitfalls. two case reports.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Catheterization and cardiovascular diagnosis     Volume:  45     ISSN:  0098-6569     ISO Abbreviation:  Cathet Cardiovasc Diagn     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1999-01-20     Completed Date:  1999-01-20     Revised Date:  2013-05-24    
Medline Journal Info:
Nlm Unique ID:  7508512     Medline TA:  Cathet Cardiovasc Diagn     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  272-4     Citation Subset:  IM    
Affiliation:
Thoracic and Cardiovascular Institute, Lansing, Michigan 48910, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty* / adverse effects
Antibodies, Monoclonal / administration & dosage,  therapeutic use*
Anticoagulants / administration & dosage,  therapeutic use
Blood Flow Velocity
Female
Follow-Up Studies
Graft Occlusion, Vascular / diagnosis,  physiopathology,  therapy*
Heparin / administration & dosage,  therapeutic use
Humans
Immunoglobulin Fab Fragments / administration & dosage,  therapeutic use*
Infusions, Intravenous
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage,  therapeutic use*
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
Prosthesis Failure
Renal Artery / radiography,  ultrasonography
Renal Artery Obstruction / diagnosis,  physiopathology,  therapy*
Reoperation
Stents
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Anticoagulants; 0/Immunoglobulin Fab Fragments; 0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 9005-49-6/Heparin; X85G7936GV/abciximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transcatheter closure of an anomalous venous connection by a novel method.
Next Document:  Primary stent implantation for acute myocardial infarction during pregnancy: use of abciximab, ticlo...